ASSOCIATION OF CYTOMEGALOVIRUS DNA CONCENTRATION IN EPITHELIAL LINING FLUID AND SYMPTOMATIC CYTOMEGALOVIRUS INFECTION IN LUNG TRANSPLANT RECIPIENTS
Authors:
- Peter JakschPJPeter Jaksch
- Claudia BauerCBClaudia Bauer
- Therese PopowTPTherese Popow
- Walter KlepetkoWKWalter Klepetko
- Hanns HofmannHHHanns Hofmann
- Elisabeth Puchhammer-StöcklEPElisabeth Puchhammer-Stöckl
- 1 June 2004
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 77 (12) , 1897-1899
Abstract
The authors have investigated the effectiveness of virus detection from bronchoalveolar lavage (BAL) samples for the identification of symptomatic cytomegalovirus (CMV) infection in lung transplant recipients. Thus, 275 BAL samples taken from 105 lung transplant recipients during follow-up were analyzed by quantitative polymerase chain reaction (PCR) and virus isolation. Quantitative PCR detected virus in all 24 BAL samples taken at onset of symptomatic disease, and virus culture in only 7 samples (29.2%). Twenty-three of 251 BAL samples (9.2%) were positive by PCR, although they were obtained in an asymptomatic phase. Quantitation of CMV DNA from BAL allowed no discrimination between symptomatic and asymptomatic infection in individual cases. However, when the urea dilution method was used to recalculate the CMV DNA concentration for the epithelial lining fluid (ELF) diluted in the BAL, a CMV DNA level of more than 10 copies/mL ELF was clearly associated with symptomatic disease. The CMV DNA level in ELF may be a marker for symptomatic CMV infection.Keywords
This publication has 10 references indexed in Scilit:
- Randomized controlled trial of oral ganciclovir versus oral acyclovir after induction with intravenous ganciclovir for long-term prophylaxis of cytomegalovirus disease in cytomegalovirus-seropositive liver transplant recipientsTransplantation, 2003
- Epidemiology and Management of Infections after Lung TransplantationClinical Infectious Diseases, 2001
- Quantification of Cytomegalovirus DNA in BAL FluidChest, 2000
- HUMAN CYTOMEGALOVIRUS (HCMV) LEUKODNAEMIA CORRELATES MORE CLOSELY WITH CLINICAL SYMPTOMS THAN ANTIGENEMIA AND VIREMIA IN HEART AND HEART-LUNG TRANSPLANT RECIPIENTS WITH PRIMARY HCMV INFECTION1Transplantation, 1998
- Should cytomegalovirus be tested for in both blood and bronchoalveolar lavage fluid of patients at a high risk of CMV pneumonia after bone marrow transplantation?British Journal of Haematology, 1997
- PREDICTIVE VALUE OF CYTOMEGALOVIRUS DNA DETECTION BY POLYMERASE CHAIN REACTION IN BLOOD AND BRONCHOALVEOLAR LAVAGE IN LUNG TRANSPLANT PATIENTS1Transplantation, 1997
- PREDICTION OF CYTOMEGALOVIRUS PNEUMONIA AFTER MARROW TRANSPLANTATION FROM CELLULAR CHARACTERISTICS AND CYTOMEGALOVIRUS CULTURE OF BRONCHOALVEOLAR LAVAGE FLUIDTransplantation, 1994
- THE DIAGNOSIS OF CMV PNEUMONITIS IN LUNG AND HEART/LUNG TRANSPLANT PATIENTS BY PCR COMPARED WITH TRADITIONAL LABORATORY CRITERIATransplantation, 1993
- Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilutionJournal of Applied Physiology, 1986
- Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigenJournal of Clinical Microbiology, 1984